

Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Crohn disease | D003424 | EFO_0000384 | K50 | — | 1 | — | — | — | 1 |
| Drug common name | EDICOTINIB |
| INN | edicotinib |
| Description | Edicotinib is a small molecule pharmaceutical. It is currently being investigated in clinical studies. The pharmaceutical is active against macrophage colony-stimulating factor 1 receptor. In addition, it is known to target receptor-type tyrosine-protein kinase FLT3 and mast/stem cell growth factor receptor Kit. |
| Classification | Small molecule |
| Drug class | tyrosine kinase inhibitors |
| Image (chem structure or protein) | ![]() |
| Structure (InChI/SMILES or Protein Sequence) | CC1(C)CC=C(c2nc(C3CC(C)(C)OC(C)(C)C3)ccc2NC(=O)c2nc(C#N)c[nH]2)CC1 |
| PDB | — |
| CAS-ID | 1142363-52-7 |
| RxCUI | — |
| ChEMBL ID | CHEMBL3674570 |
| ChEBI ID | — |
| PubChem CID | — |
| DrugBank | — |
| UNII ID | 3NU609VYNF (ChemIDplus, GSRS) |
